Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 25, 2017
Pharmacy Choice - Pharmaceutical News - ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) Files An 8-K Results of Operations and Financial Condition - May 25, 2017

Pharmacy News Article

 5/19/17 - ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) Files An 8-K Results of Operations and Financial Condition

ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) Files An 8-K Results of Operations and Financial Condition

Item 2.02

Results of Operations and Financial
Condition

On May 18, 2017 we issued a press release announcing the
announced that we completed enrollment and initiated dosing in a
second Phase 1 human pharmacokinetic trial of LTX-04, our lead
development candidate utilizing our LIMITx technology. A copy of
our press release is being filed as Exhibit 99.1 hereto.

Item 9.01 Financial Statements and Exhibits
Exhibit Number Description
99.1 Press Release dated May 18, 2017

About ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR)
Acura Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication abuse and misuse. The Company has discovered and developed three platform technologies, which can be used to develop multiple products. The Company's Oxaydo Tablets (oxycodone HCl, CII), which utilizes the Aversion Technology, is an approved and immediate-release (IR) oxycodone product in the United States. The Company's Impede technology products include Nexafed and Nexafed Sinus Pressure + Pain. Its third deterrent technology is Limitx, which is designed to retard the release of active drug ingredients when too many tablets are accidently or purposefully ingested. The Company's Aversion and Limitx technologies are intended to address methods associated with opioid and its Impede technology is directed at the extraction and conversion of pseudoephedrine into methamphetamine. ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) Recent Trading Information
ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) closed its last trading session down -0.017 at 0.503 with 513,075 shares trading hands.

The post ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) Files An 8-K Results of Operations and Financial Condition appeared first on Market Exclusive.



© Market Exclusive 2017

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
May 25: Acne Vulgaris: Comprehensive Pharmaceutical Care
Last Chance
May 26: Dispensing Controlled Substances in Today’s Pharmacy
May 30: The American Geriatric Society Beers Criteria: Implications for Pharmacy Practice
May 31: Medication Safety & Drug Safety Alerts
Jun 01: Adult Immunizations: A Guide for Pharmacists, Techs & NPs
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415